The Valley Desk

NCT04625647 · Interventional trial

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Overall registry status Active not recruiting

Phase 2

Conditions Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov